[Effector proteins of Clamidia]
- PMID: 20088373
[Effector proteins of Clamidia]
Abstract
The review summarizes the recent published data on molecular mechanisms of Chlamidiae - host cell interaction, first of all on chlamydial effector proteins. Such proteins as well as III transport system proteins that transfer many effector proteins into host cytoplasm are attractive targets for drug therapy of chlamydial infections. The majority of the data concerns two species, Chlamydia trachomatis and Chlamydophila pneumoniae. C. trachomatis protein TARP, which is presynthesized in elementary bodies, plays an essential role in the initial stages of the infection. Patogen proteins participating in the next stage, that is the intracellular inclusion traffic to the centrosome, are CT229 of C. trachomatis and Cpn0585 of C. pneumoniae, which interact with cellular Rab GTPases. In C. trachomatis, IncA protein plays a key role in chlamydial inclusions fusion, CT847 modulates life cycle of the host cell, LDA3 is essential in acquisition of nutrients. CPAF protease and inclusion membrane proteins IncG and CADD participate in suppression of apoptosis of infected cells. The proteases CPAF and CT441, as well as deubiquitinating ChlaDub1 protein, contribute to avoiding the immune response.
Similar articles
-
Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells.Microb Pathog. 2008 Apr;44(4):279-85. doi: 10.1016/j.micpath.2007.10.002. Epub 2007 Oct 18. Microb Pathog. 2008. PMID: 17997273
-
Identification and characterization of secreted effector proteins of Chlamydophila pneumoniae TW183.Res Microbiol. 2006 Jul-Aug;157(6):513-24. doi: 10.1016/j.resmic.2005.12.005. Epub 2006 Feb 8. Res Microbiol. 2006. PMID: 16797933
-
The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis.Infect Immun. 2006 Aug;74(8):4826-40. doi: 10.1128/IAI.00081-06. Infect Immun. 2006. PMID: 16861671 Free PMC article.
-
Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview.Clin Microbiol Infect. 2009 Jan;15(1):36-41. doi: 10.1111/j.1469-0691.2008.02631.x. Clin Microbiol Infect. 2009. PMID: 19220338 Review.
-
Chlamydial persistence: beyond the biphasic paradigm.Infect Immun. 2004 Apr;72(4):1843-55. doi: 10.1128/IAI.72.4.1843-1855.2004. Infect Immun. 2004. PMID: 15039303 Free PMC article. Review. No abstract available.
Cited by
-
Bioprospecting by Phage Display of Mimetic Peptides of Chlamydia trachomatis for Use in Laboratory Diagnosis.Infect Drug Resist. 2022 Aug 30;15:4935-4945. doi: 10.2147/IDR.S369339. eCollection 2022. Infect Drug Resist. 2022. PMID: 36065279 Free PMC article.
-
Recombinant Cpn 0810 stimulates proinflammatory cytokine expression and apoptosis in human monocytes.Exp Ther Med. 2015 Feb;9(2):459-463. doi: 10.3892/etm.2014.2111. Epub 2014 Dec 5. Exp Ther Med. 2015. PMID: 25574216 Free PMC article.
-
Identification of the alternative sigma factor regulons of Chlamydia trachomatis using multiplexed CRISPR interference.mSphere. 2023 Oct 24;8(5):e0039123. doi: 10.1128/msphere.00391-23. Epub 2023 Sep 25. mSphere. 2023. PMID: 37747235 Free PMC article.
-
Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection.Biomaterials. 2012 Jul;33(20):5166-74. doi: 10.1016/j.biomaterials.2012.03.054. Epub 2012 Apr 9. Biomaterials. 2012. PMID: 22494890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical